Skip to content

Actelion

Pharma·Switzerland·Exited 2017·Held 19yr
Entry
1998
Hold
19yr
Exit
2017

Who owns Actelion?

Actelion was owned by Wellington Partners through Wellington Partners Life Sciences (1998 vintage) from 1998 to 2017, exited via Trade Sale. Across its history, Actelion has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

Wellington Partners
Most recent investor
Wellington Partners
Wellington Partners Life Sciences · 1998 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorPharma
Key takeaways
  • ·Fully exited in 2017.
  • ·Average hold across 2 realized cycles: 19 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2017 to .
Co-invest · 2 holders · 1998 · 2017
Cita Investissement
1998 · 2017(19yr) · CITA Investissement · 1991 · Growth
Trade Sale · to
MOIC
–
Wellington Partners
1998 · 2017(19yr) · Wellington Partners Life Sciences · 1998 · VC
Trade Sale · to
MOIC
–
Track Actelion

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Actelion?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Actelion.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue